Evidence map›Paper›PMID 22675000›Full record

ArticleJournal of virology2012

FOXO3 regulates the CD8 T cell response to a chronic viral infection.

Jeremy A Sullivan, Eui Ho Kim, Erin H Plisch, M Suresh

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 51 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Role of Medaka (Animals : an open access journal from MDPI · 2024
    Article
  6. mBio · 2023
    Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Potential of natural astaxanthin in alleviating the risk of cytokine storm in COVID-19.Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie · 2020
    Review
  13. Article
  14. Review
  15. Review
  16. Review
  17. FOXOs in cancer immunity: Knowns and unknowns.Seminars in cancer biology · 2018
    Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Jeremy A SullivanDepartment of Pathobiological Sciences, University of Wisconsin-Madison, Madison, Wisconsin, USA.
Eui Ho Kim
Erin H Plisch
M Suresh
University of Wisconsin–Madison · US

Funding

Regulation of CD8 T Cell Immunity by TNF ReceptorsR01AI048785 · NIAID · UNIVERSITY OF WISCONSIN-MADISON · PI SURESH, MARULASIDDAPPA · 2002 to 2012
$3.3M
REGULATION OF CD8 T CELL IMMUNITY BY TNF RECEPTORSR21AI048785 · NIAID · UNIVERSITY OF WISCONSIN MADISON · PI SURESH, MARULASIDDAPPA · 2001 to 2001
$291k
NIAID NIH HHS AI048785NIAID NIH HHS R01 AI048785NIAID NIH HHS R21 AI048785
6 · The paper itself

Abstract

Chronic infections with viruses such as hepatitis B virus, hepatitis C virus, and HIV constitute a major global public health problem. Studies of chronic viral infections in humans and mice show that persistent antigenic stimulation induces dysregulation of T cell responses; virus-specific T cells either undergo clonal deletion or lose their ability to display the full spectrum of effector functions, a condition termed functional exhaustion. The ability to generate and retain sufficient numbers of functionally competent T cells, therefore, becomes vitally important in controlling chronic viral infections. Our understanding of the mechanisms governing T cell homeostasis during chronic viral infections, however, is poor. The phosphatidylinositol 3-kinase (PI3K)/Akt signaling pathway controls cell fate decisions in many cell types by modulating the activity of downstream effectors, including the FOXO family of transcription factors. We have observed dynamic, in vivo alterations in the phosphorylation levels of three key proteins (Akt, FOXO1/FOXO3 [FOXO1/3], and mammalian target of rapamycin [mTOR]) involved in this signaling cascade and have identified the transcription factor FOXO3 as a negative regulator of the magnitude and effector function of CD8 T cells during chronic lymphocytic choriomeningitis virus (LCMV) infection in mice. We report that ablation of FOXO3 in T cells reduced apoptosis, increased the abundance of polyfunctional virus-specific CD8 T cells, and improved viral control. Thus, FOXO3 is a promising candidate target for immunotherapies of chronic viral infection.

Indexed as

AnimalsCD8-Positive T-LymphocytesForkhead Box Protein O3Forkhead Transcription FactorsHumansLymphocytic ChoriomeningitisLymphocytic choriomeningitis virusMiceMice, Inbred C57BLMice, KnockoutForkhead Box Protein O3Forkhead Transcription FactorsFoxO3 protein, mouse

Identifiers

PMID22675000
PMCPMC3416126
OpenAlexW2106870605

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.